XML 34 R23.htm IDEA: XBRL DOCUMENT v3.20.4
BASIS OF PRESENTATION AND SUMMARY OF ACCOUNTING POLICIES - Additional information (Details)
3 Months Ended 12 Months Ended
Jan. 13, 2021
USD ($)
$ / shares
shares
Dec. 10, 2020
USD ($)
Oct. 07, 2020
USD ($)
May 01, 2020
USD ($)
Dec. 31, 2020
USD ($)
customer
$ / shares
shares
Dec. 31, 2019
USD ($)
customer
Sep. 30, 2020
USD ($)
customer
$ / shares
Jan. 31, 2021
USD ($)
Concentration Risk [Line Items]                
Retained Earnings (Accumulated Deficit)         $ (274,645,206)   $ (269,835,650)  
Net loss         (4,807,062) $ (2,662,741)    
Negative operating cash flow         4,155,742 2,731,273    
Cash and cash equivalents         4,241,407   $ 7,786,743  
Working Capital Surplus Deficit         $ 3,621,859      
Common Stock, Par Or Stated Value Per Share | $ / shares         $ 0.001   $ 0.001  
Research and development         $ 748,365 564,426    
Allowance on accounts receivable (in dollars)         $ 11,968   $ 11,968  
Depreciation method         straight line method      
Net proceeds from exercise of warrants   $ 1,100,000     $ 2,605,529 $ 0    
Excess of FDIC insurance limit         $ 4,000,000      
PPP Loan                
Concentration Risk [Line Items]                
Proceeds from Issuance of Debt       $ 847,000        
Public Offering                
Concentration Risk [Line Items]                
Number of warrants exercised | shares         518,551      
Net proceeds from exercise of warrants     $ 1,669,500   $ 2,600,000      
Subsequent event                
Concentration Risk [Line Items]                
Cash balance               $ 16,500,000
Subsequent event | Public Offering                
Concentration Risk [Line Items]                
Number of common stock issued | shares 1,810,000              
Public offering price for each share together with warrant | $ / shares $ 8.30              
Gross proceeds of offering before underwriter discounts, commissions and other offering expenses $ 15,000,000              
Net proceeds of offering after underwriter discounts, commissions and other offering expenses $ 14,000,000              
Computer equipment                
Concentration Risk [Line Items]                
Estimated useful life for computer equipment, lab equipment and furniture         P3Y      
Construction in progress         $ 1,267,802   $ 214,101  
Lab equipment                
Concentration Risk [Line Items]                
Estimated useful life for computer equipment, lab equipment and furniture         P3Y      
Furniture                
Concentration Risk [Line Items]                
Estimated useful life for computer equipment, lab equipment and furniture         P3Y      
Total Revenue                
Concentration Risk [Line Items]                
Number of customers | customer         2 3    
Total Revenue | One customer                
Concentration Risk [Line Items]                
Concentration risk percentage         26.00% 27.00%    
Total Revenue | Two customer                
Concentration Risk [Line Items]                
Concentration risk percentage         10.00% 22.00%    
Total Revenue | Three customers                
Concentration Risk [Line Items]                
Concentration risk percentage           10.00%    
Accounts Receivable | Three customers                
Concentration Risk [Line Items]                
Concentration risk percentage         61.00%      
Number of customers | customer         3      
Accounts Receivable | Four customer                
Concentration Risk [Line Items]                
Concentration risk percentage             74.00%  
Number of customers | customer             4